Histamines are chemicals that are usually responsible for causing allergic reactions. However, research shows they may also help treat multiple sclerosis.

Statin drugs are normally used to treat high cholesterol. Now, research shows that they may also help multiple sclerosis (MS) patients manage their disease.

Pharmaceutical company Novartis AG's multiple sclerosis (MS) drug, Gilenya, has been approved for use in the United States and now Europe to treat relapsing-remitting forms of the disease.

New guidelines recommend plasma exchange for patients with severe relapses of multiple sclerosis (MS) and for those with nerve disorders such as neuropathy.

A "master switch" protein in white blood cells has been found to influence whether the cells promote or hinder inflammation, according to a new study.

In multiple sclerosis (MS), white blood cells known as leukocytes enter the central nervous system (CNS) with help from a family of molecules (MMPs) and then damage the protective coating called myelin around nerves.

Harry Potter scribe J.K. Rowling has donated £10 million to the University of Edinburgh to establish the Anne Rowling Regenerative Neurology Clinic.

In search of the cause of multiple sclerosis (MS), researchers are currently examining the genetic environment in which the disease arises.

Rochester drug company Vaccinex, Inc., a spinoff from the University of Rochester, has seen some success with its antibody therapy for combatting cancer.

Trigeminal neuralgia, a painful condition occurring in patients with multiple sclerosis (MS), can be effectively treated with stereotactic radiation (radiosurgery), a specialized radiation therapy that focuses radiation beams on a well-defined area.